INOVIO PHARMACEUTICALS, INC.: accounts_receivable
| Value | {"amount": 3301563, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2013-12-31) |
| Status | current |
| Entity | INOVIO PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:22:42.236691+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/2b1729eb-ab5f-416d-8e8b-e7b3e5e44736
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001055726-14-000003 · Open the official SEC filing →Retrieved: 2026-08-19T10:22:42.236691+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001055726/accounts-receivable/2013-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/2b1729eb-ab5f-416d-8e8b-e7b3e5e44736
History
- no predecessors — first report